NASDAQ : TPST
Tempest Therapeutics, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 0.4955 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 8.20M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 18.62M | 13.97M | 13.55M | 11.66M | 12.11M | 9.82M |
| Research & Development | 3.04M | 12.61M | 28.48M | 17.50M | 22.53M | 17.17M |
| Operating Expenses | 21.66M | 26.57M | 42.03M | 29.16M | 34.64M | 26.99M |
| Operating Income | -21.66M | -26.57M | -42.03M | -29.16M | -34.64M | -26.99M |
| Interest Expense | -207.00K | -1.32M | -1.45M | -1.62M | -1.28M | |
| Interest & Investment Income | 170.00K | 520.00K | 1.50M | 1.11M | 549.00K | |
| Other Non Operating Income (Expenses) | -34.00K | |||||
| Pretax Income | -40.47M | -26.26M | -41.84M | -29.49M | -35.71M | -28.30M |
| Net Income | -40.47M | -26.26M | -41.84M | -29.49M | -35.71M | -28.30M |
| Net Income to Common | -40.47M | -26.26M | -41.84M | -29.49M | -35.71M | -28.30M |
| Shares Outstanding (Basic) | 8.88M | 4.15M | 2.15M | 1.19M | 888.38K | 291.56K |
| Shares Outstanding (Diluted) | 8.88M | 4.15M | 2.15M | 1.19M | 888.38K | 291.56K |
| EPS (Basic) | -4.56 | -6.33 | -19.50 | -24.87 | -40.20 | -97.07 |
| EPS (Diluted) | -4.56 | -6.33 | -19.50 | -24.87 | -40.20 | -97.07 |
| Free Cash Flow | -20.73M | -26.82M | -33.46M | -27.53M | -31.63M | -26.09M |
| Free Cash Flow Per Share | -2.33 | -6.46 | -15.59 | -23.21 | -35.61 | -89.49 |
| EBITDA | -21.41M | -26.31M | -41.64M | -28.78M | -34.00M | -26.61M |
| D&A For EBITDA | 251.00K | 266.00K | 389.00K | 381.00K | 638.00K | 374.00K |
| EBIT | -21.66M | -26.57M | -42.03M | -29.16M | -34.64M | -26.99M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 779.00K | 7.71M | 30.27M | 39.23M | 31.23M | 51.83M |
| Cash & Short-Term Investments | 779.00K | 7.71M | 30.27M | 39.23M | 31.23M | 51.83M |
| Prepaid Expenses | 493.00K | 196.00K | 642.00K | 700.00K | 703.00K | 949.00K |
| Other Current Assets | 425.00K | 366.00K | 564.00K | 433.00K | 1.02M | 16.18M |
| Total Current Assets | 1.70M | 8.27M | 31.47M | 40.36M | 32.95M | 68.96M |
| Property, Plant & Equipment | 7.43M | 8.14M | 9.53M | 10.79M | 12.71M | 4.16M |
| Other Long-Term Assets | 501.00K | 517.00K | 485.00K | 448.00K | 429.00K | 111.00K |
| Total Assets | 9.63M | 16.93M | 41.49M | 51.60M | 46.09M | 73.24M |
| Accounts Payable | 2.00M | 1.04M | 2.45M | 845.00K | 1.11M | 991.00K |
| Accrued Expenses | 1.17M | 1.08M | 4.55M | 3.33M | 4.31M | 2.59M |
| Current Portion of Long-Term Debt | 6.35M | 4.29M | ||||
| Current Portion of Leases | 1.29M | 1.19M | 869.00K | 952.00K | 1.41M | 1.44M |
| Other Current Liabilities | 450.00K | 15.00M | ||||
| Total Current Liabilities | 4.45M | 3.31M | 14.22M | 9.41M | 7.28M | 20.03M |
| Long-Term Debt | 6.26M | 10.37M | 15.07M | |||
| Long-Term Leases | 6.27M | 6.95M | 8.14M | 9.16M | 10.33M | 2.03M |
| Total Liabilities | 10.72M | 10.26M | 22.36M | 24.84M | 27.98M | 37.12M |
| Common Stock | 16.00K | 5.00K | 3.00K | 22.00K | 11.00K | 7.00K |
| Additional Paid-In Capital | 274.21M | 240.03M | 226.23M | 192.01M | 153.87M | 136.17M |
| Retained Earnings | -275.32M | -233.37M | -207.11M | -165.26M | -135.77M | -100.06M |
| Total Common Equity | -1.09M | 6.67M | 19.13M | 26.77M | 18.11M | 36.12M |
| Shareholders' Equity | -1.09M | 6.67M | 19.13M | 26.77M | 18.11M | 36.12M |
| Total Liabilities & Equity | 9.63M | 16.93M | 41.49M | 51.60M | 46.09M | 73.24M |
| Total Debt | 7.56M | 8.14M | 15.37M | 20.66M | 22.11M | 18.54M |
| Net Cash (Debt) | -6.78M | -434.00K | 14.90M | 18.57M | 9.12M | 33.29M |
| Net Cash Per Share | -0.76 | -0.10 | 6.94 | 15.66 | 10.26 | 114.18 |
| Filing Date Shares Outstanding | 15.98M | 14.34M | 3.50M | 1.71M | 812.44K | 551.78K |
| Total Common Shares Outstanding | 15.98M | 4.93M | 3.38M | 1.70M | 809.12K | 531.56K |
| Working Capital | -2.75M | 4.96M | 17.25M | 30.95M | 25.67M | 48.94M |
| Book Value Per Share | -0.07 | 1.35 | 5.65 | 15.78 | 22.38 | 67.94 |
| Tangible Book Value | -1.09M | 6.67M | 19.13M | 26.77M | 18.11M | 36.12M |
| Tangible Book Value Per Share | -0.07 | 1.35 | 5.65 | 15.78 | 22.38 | 67.94 |
| Machinery | 1.86M | 1.86M | 2.00M | 1.63M | 1.54M | 1.10M |
| Leasehold Improvements | 198.00K | 198.00K | 201.00K | 235.00K | 882.00K | 840.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -40.47M | -26.26M | -41.84M | -29.49M | -35.71M | -28.30M |
| Depreciation & Amortization | 251.00K | 266.00K | 389.00K | 381.00K | 638.00K | 374.00K |
| Stock-Based Compensation | 746.00K | 3.12M | 5.30M | 2.55M | 1.56M | 1.10M |
| Other Operating Activities | 2.87M | 1.19M | 1.51M | 1.88M | 1.57M | 1.48M |
| Change in Accounts Payable | -2.72M | -1.41M | 1.60M | -263.00K | 1.00K | -209.00K |
| Change in Other Net Operating Assets | -1.33M | -3.72M | 8.00K | -2.41M | 867.00K | -404.00K |
| Operating Cash Flow | -20.73M | -26.82M | -33.03M | -27.36M | -31.07M | -25.96M |
| Capital Expenditures | -435.00K | -170.00K | -562.00K | -135.00K | ||
| Other Investing Activities | 38.00K | |||||
| Investing Cash Flow | -435.00K | -170.00K | -562.00K | -97.00K | ||
| Long-Term Debt Issued | 15.00M | |||||
| Long-Term Debt Repaid | -6.43M | -4.40M | -4.74M | |||
| Net Debt Issued (Repaid) | -6.43M | -4.40M | -4.74M | 15.00M | ||
| Issuance of Common Stock | 3.92M | 7.38M | 28.90M | 35.60M | 8.86M | 33.53M |
| Other Financing Activities | 3.31M | 3.31M | 7.28M | 10.53M | ||
| Financing Cash Flow | 7.23M | 4.26M | 24.50M | 35.60M | 11.40M | 59.06M |
| Net Cash Flow | -13.50M | -22.56M | -8.96M | 8.07M | -20.23M | 33.01M |
| Free Cash Flow | -20.73M | -26.82M | -33.46M | -27.53M | -31.63M | -26.09M |
| Free Cash Flow Per Share | -2.33 | -6.46 | -15.59 | -23.21 | -35.61 | -89.49 |
| Levered Free Cash Flow | -15.51M | -17.59M | -19.08M | -17.47M | -18.33M | -16.38M |
| Unlevered Free Cash Flow | -15.51M | -17.46M | -18.26M | -16.57M | -17.32M | -15.58M |
| Cash Interest Paid | 192.00K | 1.18M | 1.25M | 1.54M | 953.00K | |
| Cash Income Tax Paid | 86.00K | 43.00K | 54.00K | 191.00K | 18.00K | |
| Change in Working Capital | -4.06M | -5.13M | 1.61M | -2.68M | 868.00K | -613.00K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 7.81M | 14.14M | 36.42M | 84.69M | 12.09M | 36.49M |
| Enterprise Value | 14.59M | 15.03M | 32.04M | 94.58M | -13.99M | -4.42M |
| Last Close Price | 0.50 | 2.87 | 10.85 | 57.20 | 14.95 | 68.64 |
| PB Ratio | 2.12 | 1.90 | 3.16 | 0.67 | 1.01 | |
| P/TBV Ratio | 2.12 | 1.90 | 3.16 | 0.67 | 1.01 | |
| Debt / Equity Ratio | -6.94 | 1.22 | 0.80 | 0.77 | 1.22 | 0.51 |
| Net Debt / Equity Ratio | -6.22 | 0.07 | -0.78 | -0.69 | -0.50 | -0.92 |
| Net Debt / EBITDA Ratio | -0.32 | -0.02 | 0.36 | 0.65 | 0.27 | 1.25 |
| Net Debt / FCF Ratio | -0.33 | -0.02 | 0.45 | 0.68 | 0.29 | 1.28 |
| Quick Ratio | 0.17 | 2.33 | 2.13 | 4.17 | 4.29 | 2.59 |
| Current Ratio | 0.38 | 2.50 | 2.21 | 4.29 | 4.53 | 3.44 |
| Return on Equity (ROE) | -931.14% | -203.63% | -182.35% | -131.42% | -131.70% | -104.76% |
| Return on Assets (ROA) | -79.37% | -56.86% | -56.43% | -37.31% | -36.29% | -35.10% |
| Return on Capital Employed (ROCE) | -417.90% | -195.20% | -154.10% | -69.10% | -89.30% | -50.70% |
| Earnings Yield | -964.77% | -185.72% | -114.89% | -34.82% | -295.25% | -77.57% |
| FCF Yield | -252.95% | -189.66% | -91.88% | -32.50% | -261.55% | -71.51% |
| Buyback Yield / Dilution | -186.97% | -93.35% | -80.99% | -33.49% | -204.70% | -709.62% |